Which mechanism of action distinguishes irreversible cholinesterase inhibitors from reversible inhibitors?

Explanation

## Reversible vs. Irreversible Cholinesterase Inhibitors **Key Point:** Irreversible inhibitors form a covalent phosphoester bond with the serine hydroxyl group in the active site of acetylcholinesterase (AChE), creating a stable complex that cannot be readily hydrolyzed. Reversible inhibitors bind through weak non-covalent interactions. ### Mechanism Comparison | Feature | Reversible Inhibitors | Irreversible Inhibitors | |---------|---|---| | Binding Type | Non-covalent (hydrogen bonds, van der Waals) | Covalent phosphoester bond | | Target Residue | Anionic site, esteric site | Serine hydroxyl (nucleophilic) | | Enzyme Recovery | Spontaneous (minutes to hours) | Requires new enzyme synthesis (days) | | Examples | Physostigmine, neostigmine, donepezil | Organophosphates, echothiophate | | Clinical Antidote | Supportive care | Pralidoxime (PAM) + atropine | **High-Yield:** Organophosphate compounds (pesticides, nerve agents) are irreversible inhibitors. They phosphorylate the serine residue, and if not reversed quickly by pralidoxime (before "aging"), the enzyme is permanently inactivated. **Mnemonic:** **OPIE = Organophosphates = Phosphorylate = Irreversible** **Clinical Pearl:** The term "aging" refers to loss of an alkyl group from the phosphorylated enzyme, making it resistant to pralidoxime reversal. This is why pralidoxime must be given early in organophosphate poisoning (within 24–48 hours). ### Mechanism Diagram ```mermaid flowchart TD A[Cholinesterase Inhibitor]:::outcome --> B{Type?}:::decision B -->|Reversible| C[Weak non-covalent binding]:::action C --> D[Rapid spontaneous dissociation]:::action D --> E[Enzyme recovers in minutes-hours]:::outcome B -->|Irreversible| F[Covalent phosphoester bond]:::action F --> G[Serine residue phosphorylated]:::action G --> H{Aging occurred?}:::decision H -->|No| I[Pralidoxime can reverse]:::action H -->|Yes| J[Permanent inactivation]:::urgent J --> K[New enzyme synthesis required]:::outcome ```